BANK VONTOBEL/CALL/ROCHE GS/260/0.02/20.12.24 Share Price

Warrant

WROA0V

CH1245835561

Real-time Bid/Ask 03:58:09 27/06/2024 pm IST
0.184 CHF / 0.194 CHF -8.25% Intraday chart for BANK VONTOBEL/CALL/ROCHE GS/260/0.02/20.12.24
Current month+110.20%
1 month+90.74%
Date Price Change
26/24/26 0.206 -3.74%
25/24/25 0.214 -10.08%
24/24/24 0.238 +9.17%
21/24/21 0.218 +15.96%
20/24/20 0.188 +1.08%

Delayed Quote Swiss Exchange

Last update June 26, 2024 at 08:45 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Vontobel Vontobel
WROA0V
ISINCH1245835561
Date issued 14/03/2023
Strike 260 CHF
Maturity 20/12/2024 (177 Days)
Parity 50 : 1
Emission price 0.45 CHF
Emission volume N/A
Settlement Por entregas
Currency CHF

Technical Indicators

Highest since issue 0.92 CHF
Lowest since issue 0.05 CHF
Delta0.43x
Omega 11.60
Premium7.4x
Gearing26.82x
Moneyness 0.9646
Difference Strike 9.65 CHF
Difference Strike %+3.71%
Spread 0.01 CHF
Spread %5.21%
Theoretical value 0.1870
Implied Volatility 18.05 %
Total Loss Probability 61.60 %
Intrinsic value 0.000000
Present value 0.1870
Break even 269.35 CHF
Theta-0.01x
Vega0.01x
Rho0.01x

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
249.6 CHF
Average target price
278.1 CHF
Spread / Average Target
+11.40%
Consensus
  1. Stock Market
  2. Warrants
  3. WROA0V Warrant